CompletedPhase 4ketamine
IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D
Sponsored by University of Tennessee
NCT ID
NCT02635282
Target Enrollment
19 participants
Start Date
2016-08
Est. Completion
2017-03-23
About This Study
The general objective of this study is to determine whether intranasal ketamine should be incorporated into formulary as an option to treat pain during minor procedures in the pediatric emergency department.
Conditions Studied
Interventions
- •intranasal ketamine
- •intranasal fentanyl
- •intranasal midazolam
Eligibility
Age:3 Years - 17 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria: * Diagnosis of abscess with planned incision and drainage of a single abscess Exclusion Criteria: * Fast Track patients * Patients who have received an opioid analgesic within the previous 4 hours of time of enrollment in study * Patients with parent or legal guardian not present to give informed consent for enrollment in study * Non-English speaking patients and/or parent * Patients with a contraindication for the administration of intranasal medication (nasal trauma, aberrant nasal anatomy) * Patients with ocular injuries * Patients with a known allergy to ketamine, fentanyl, and/or midazolam * Pregnant females * Patients with history of seizure disorders
Study Locations (1)
Le Bonheur Children's Hospital
Memphis, Tennessee, United States